Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2017
|
RARE |
|
Phase 3 Results |
Neurology |
None |
|
Not General
|
TBPH |
|
Phase 2b Results |
Other |
None |
|
H2 2017
|
TBPH |
|
Phase 3 Results |
Infectious Disease |
Fast Track |
|
H2 2017
|
TCON |
|
Phase 1/2 Results |
Oncology |
None |
|
Q4 2017
|
VICL |
|
Phase 3 Results |
Other |
Orphan Drug |
|
Q1 2018
|
GLMD |
|
Phase 2b Results |
Other |
None |
|
Q1 2018
|
AVEO |
|
Phase 3 Results |
Oncology |
None |
|
Q1 2018
|
PRTA |
|
Phase 2b Results |
Endocrine |
Fast Track |
|
Q1 2018
|
VTVT |
|
Phase 2b Results |
Neurology |
Fast Track, Special Protocol Assessment |
|
Q1 2018
|
ALNY |
|
Phase 3 Results |
Other |
Orphan Drug |
|